Hong Kong Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind his company’s success. Benjamin, as an industry veteran within the Hong Kong medical devices sector, with also a factory…
Hong Kong Winnie Lun and Dr. Patrick Leung, CEO and CSO of eNano Health, shares the serendipitous story of how they came to establish eNano Health in Hong Kong in 2010; their first flagship product, the Kiss and Tell Glucose Meter, and their expansion into other diagnostic areas; as well as their…
Hong Kong Professor Justin Wu, chief operating officer of the Chinese University of Hong Kong (CUHK) Medical Center, shares his professional background and interest in gastroenterology, his insights into the research and commercialization environment in Hong Kong, and his hope for government, industry and academia to work together to propel Hong Kong…
China Xie Yuehui, chairman and CEO of Lifetech Scientific, one of Shenzhen’s leading medical devices companies, share the company’s focus on developing innovative minimally invasive interventional medical devices to global standards, the company’s strengths in commercialization, as well as his strategic plans for the future. Mr. Xie, could you please…
China Dr. Harley Seyedin, president of AmCham South China, talks up increasing connectivity in the region, competition and collaboration between the Greater Bay Area cities, and their potential for international life sciences investors. Harley, you have been in the South China region as an extremely successful businessman for nearly three decades.…
Hong Kong Merck Hong Kong’s Hee-sun Lee gives her first impressions of the Hong Kong market, her main priorities, upcoming product launches and tapping into the territory’s R&D ecosystem. Hee-sun, having joined Merck Pharmaceutical Hong Kong in February 2018 from the South Korean affiliate, what are your first impressions of the market…
Hong Kong Ir. Prof. Andros Chan, president of the Hong Kong Medical and Healthcare Device Industry Association (HKMHDIA), introduces the organization’s mandate, the emerging trends in Hong Kong medtech, and the impact of the Greater Bay Area initiative on his industry. Andros, as a founding member of the HKMHDIA, could you share…
Hong Kong The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology Parks Corporation (HKSTP) provide an update on Hong Kong’s biotech scene, government commitment to innovation, and Hong Kong’s role within the wider Greater Bay Area project. We had…
China Sheng Sitong, founder and CEO of gene sequencing device company, Considerin Group (formerly HYK Gene), discusses Considerin’s rapid expansion and the development of precision medicine in China. Mr. Sheng, could you briefly introduce your company, Considerin Group, to our international audience? “We are the only Chinese company to have our…
China Guangdong province and neighbouring Hong Kong have long been fundamental to China’s metamorphosis into an economic superpower. Notable as one of the country’s most open and dynamic regions, the Pearl River Delta (PRD), as that area previously used to be known, historically formed the soft underbelly via which the outside…
China One of the more eye-catching and ambitious initiatives to come out of last March’s National People’s Congress, Premier Li Keqiang’s grand vision for the cultivation of a globally competitive cluster of metropolises and “innovation super-hub” in China’s Greater Bay Area (GBA), is now starting to take shape as the country…
China Dr. Tang Dajie, founder and CEO of investment vehicle Triwise Capital, discusses the numerous investment opportunities in Shenzhen’s life sciences sector and the city’s unique geographical and economic positioning. Dr. Tang, could you start by introducing your investment company, Triwise Capital, and the reason for its special focus on the…
See our Cookie Privacy Policy Here